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Abstract
Background: In pregnant rats, structural luteal regression takes place after parturition and is
associated with cell death by apoptosis. We have recently shown that the hormonal environment
is responsible for the fate of the corpora lutea (CL). Changing the levels of circulating hormones in
post-partum rats, either by injecting androgen, progesterone, or by allowing dams to suckle, was
coupled with a delay in the onset of apoptosis in the CL. The objectives of the present investigation
were: i) to examine the effect of exogenous estradiol on apoptosis of the rat CL during post-
partum luteal regression; and ii) to evaluate the post-partum luteal expression of the estrogen
receptor (ER) genes.
Methods: In a first experiment, rats after parturition were separated from their pups and injected
daily with vehicle or estradiol benzoate for 4 days. On day 4 post-partum, animals were sacrificed,
blood samples were taken to determine serum concentrations of hormones, and the ovaries were
isolated to study apoptosis in situ. In a second experiment, non-lactating rats after parturition
received vehicle, estradiol benzoate or estradiol benzoate plus bromoergocryptine for 4 days, and
their CL were isolated and used to study apoptosis ex vivo. In a third experiment, we obtained CL
from rats on day 15 of pregnancy and from non-lactating rats on day 4 post-partum, and studied
the expression of the messenger RNAs (mRNAs) encoding the ERalpha and ERbeta genes.
Results: Exogenous administration of estradiol benzoate induced an increase in the number of
apoptotic cells within the CL on day 4 post-partum when compared with animals receiving vehicle
alone. Animals treated with the estrogen had higher serum prolactin and progesterone
concentrations, with no changes in serum androstenedione. Administration of bromoergocryptine
blocked the increase in serum prolactin and progesterone concentrations, and DNA fragmentation
induced by the estrogen treatment. ERalpha and ERbeta mRNAs were expressed in CL of day 4
post-partum animals at levels similar to those found in CL of day 15 pregnant animals.
Conclusion: We have established that estradiol accelerates apoptosis in the CL during post-
partum luteal regression through a mechanism that possibly involves the secretion of pituitary
prolactin. We have also shown that the post-partum rat CL express ERalpha and ERbeta mRNAs
suggesting that they can be targeted by estrogen.
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Background
The regression of corpora lutea (CL) is a process that
involves two stages. During the first stage (functional
regression), production of progesterone is discontinued.
In the second stage (structural regression), the CL undergo
involution manifested by a decrease in weight and size
that is associated with programmed death of the luteal
cells [1-6]. In the rat CL, programmed cell death follows a
pattern of death by apoptosis characterized by initial con-
densation of the nuclear chromatin followed or accompa-
nied by nucleosomal fragmentation of DNA and
formation of apoptotic bodies, which eventually are elim-
inated by phagocytosis [7,8].
In the regressing CL of pregnancy, apoptosis is a lengthy
process that occurs over the course of many days from the
initial decrease in the progesterone producing capacity of
the glands, to the decrease in their sizes. As a consequence,
the structural changes of the CL undergoing regression are
usually studied after parturition [8-10]. The rat ovulates
within 24–36 h following parturition [11]. Therefore,
when studying luteal regression after parturition, two
populations of CL can be analyzed simultaneously, the CL
of previous pregnancy and the CL formed after post-par-
tum ovulation [8,12]. We have shown previously that the
two populations of CL found within the post-partum
ovary have similar rate of apoptosis despite their differ-
ence in age [10].
The regression of the CL in the rat ovary after parturition
is hormonally regulated. We demonstrated that luteal
apoptosis in this species can be accelerated by the admin-
istration of either the antigestagen RU486 or prostaglan-
din F2α [7], both of which induce large declines in the
capacity of the CL to produce progesterone. Conversely,
we and others have shown that the onset of apoptosis in
the post-partum CL can be delayed by administration of
androstenedione [9], progesterone [10], or by allowing
the dams to suckle [8,12].
During pregnancy in rats, circulating concentration of
estradiol increases on day 3, after which remains very low
until day 15–16 when it starts to increase progressively
towards parturition [13,14]. Moreover, the pregnant rat
CL express estrogen receptors (ERs) alpha (ERalpha) and
beta (ERbeta) under the regulation of prolactin and pla-
cental lactogens [15], and respond to estradiol, which
stimulates steroidogenesis [16,17], mediates luteal cell
hypertrophy by increasing protein biosynthesis [18], and
synergizes the luteotropic effect of prolactin [19]. Whether
estradiol regulates luteal function during luteal regression,
and whether ERs are expressed in the regressing CL of the
post-partum rat, is presently unknown. Therefore, in the
present investigation we studied the effect of exogenous
estradiol benzoate on apoptosis of regressing CL post-par-
tum and whether these CL express ERalpha and ERbeta
mRNAs.
Materials and methods
Animals
Pregnant (day 1 = sperm positive) Sprague-Dawley rats
were obtained from Harlan Labs (Indianapolis, IN, USA).
They were housed under controlled conditions of light
(lights on 05:00–17:00 h) and temperature (21–23°C)
with free access to standard rat chow and water. Animals
were killed by decapitation and handled in conformance
with the Guide for the Care and Use of Laboratory Ani-
mals, National Academy of Sciences, USA, 1996. The
experimental protocol was approved by the University of
South Dakota Animal Care and Use Committee.
Experimental procedure
To determine the effect of estrogen on luteal apoptosis,
two groups of post-partum rats were used, each composed
of 6 to 8 animals. The pups were removed immediately
after parturition, and the rats were injected daily with
estradiol benzoate (5 µg/rat s.c.) or vehicle (sunflower
seed oil) at 10:00 h. Animals were killed by decapitation
at 13:00 h on day 4 post-partum. Trunk blood was
obtained to determine hormone concentrations. The ova-
ries were removed and fixed for 1 h at room temperature
in 4% paraformaldehyde, dehydrated in ethanol series,
cleared in xylene, and embedded in paraffin for routine
hematoxylin and eosin (H&E) staining. Luteal regression
was evaluated separately in the two generations of CL (i.e.,
CL of the previous pregnancy and new CL formed after
ovulation post-partum) by studying the number of nuclei
undergoing apoptosis. Under the light microscope, the
old CL of pregnancy have organized cell distribution and
closed capillaries, whereas the newly formed CL have a
less organized cell distribution and open capillaries. Two
additional groups of post-partum rats, each composed of
6 to 8 animals, were treated and sacrificed as described
above, and the CL were isolated from the ovaries under a
stereoscopic microscope and weighed. The CL of the pre-
vious pregnancy were recognized from the newly formed
CL as they were larger and less vascularized.
In a second experiment three groups of rats, each com-
posed of 9 to 10 animals, were treated daily after parturi-
tion with vehicle, estradiol benzoate (5 µg/rat s.c.) or
estradiol benzoate plus bromoergocryptine (0.5 mg/rat
s.c.) at 10:00 h. Animals were killed by decapitation at
13:00 h on day 4 post-partum. Trunk blood was obtained
to determine hormone concentrations. The ovaries were
removed and the CL of previous pregnancy were isolated
under a stereoscopic microscope, pooled and used for ex
vivo incubation. The isolation of CL of the previous preg-
nancy was performed as previously reported [10]. From
the analysis of the first experiment we concluded that theReproductive Biology and Endocrinology 2005, 3:40 http://www.rbej.com/content/3/1/40
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incidence of apoptosis in both CL subtypes evaluated in
situ was similar. Therefore, for this experiment, only CL of
the previous pregnancy were used, since they are larger
and easier to isolate from the ovarian stroma than those
formed after post-partum ovulation.
In a third experiment, 3 rats per group were sacrificed at
13:00 h on day 15 of pregnancy and on day 4 post-par-
tum. In the latter group of rats, the pups were removed
immediately following parturition. The CL were isolated
from the ovaries under a stereoscopic microscope, frozen
in liquid nitrogen, and stored at -80°C until processed for
RNA isolation.
Counting of apoptotic cells
Apoptotic cells were counted in H&E stained tissue sec-
tions on the basis of morphological criteria using an opti-
cal microscope as previously described [8]. Briefly, only
cells with advanced signs of apoptosis (i.e., containing
multiple nuclear fragments) were counted. A microscope
with a 100 × objective was used and all fields were ana-
lyzed in each CL for the presence of fragmented nuclei. All
the CL in each section were studied, and an average
number of apoptotic nuclei per high power field was
obtained. The expression of apoptosis per field rather
than per CL more accurately reflects the dynamics of the
apoptotic process within each CL in a size-independent
manner at any given time after parturition. This morpho-
metric method for the identification of apoptotic cells was
previously validated in the CL by in situ 3' end labeling
[7].
Incubation of CL
The CL (four to six per well in a 24-well tissue-culture
plate) were incubated in serum-free medium (McCoy 5A:
Ham F12, 1:1, v/v; Sigma Chemical Co., St. Louis, MO,
USA) containing 25 mM Hepes, 200 IU/ml penicillin G,
200 µg/ml streptomycin, and 0.5 µg/ml of amphotericin
B at 37°C for various periods of time in an atmosphere of
95% air/5% CO2. After incubation, the CL were immedi-
ately frozen in liquid nitrogen and stored at -80°C until
DNA isolation.
DNA fragmentation
The internucleosomal cleavage of the DNA was analyzed
as follows: the CL of previous pregnancy were isolated on
day 4 post-partum and were digested overnight at 50°C in
a buffer composed of 100 mM NaCl, 10 mM Tris HCl (pH
8.0), 25 mM EDTA (pH 8.0), 0.5% SDS, and 0.1 mg/ml
proteinase K (Life Technologies, Rockville, MD, USA). The
genomic DNA was extracted from the digested tissues with
phenol/chloroform/isoamyl alcohol (25:24:1, v/v/v), pre-
cipitated, and digested for 1 h at 37°C in 1 µg/ml of ribo-
nuclease from bovine pancreas (deoxyribonuclease-free;
Roche, Indianapolis, IN, USA). After extraction and pre-
cipitation, an equal amount of DNA for each sample (1
µg) was separated by electrophoresis on a 2% agarose gel,
impregnated with SYBR Gold nucleic acid gel stain
(Molecular Probes, Eugene, OR, USA), examined using an
ultraviolet transilluminator, and photographed with the
Amersham Typhoon fluorescence imaging system (Amer-
sham Biosciences Corp., Piscataway, NJ, USA). A 100-base
pair (bp) DNA ladder (Promega, Madison, WI, USA) was
used for determining the size of the DNA fragments. The
UN-SCAN-IT gel software (Silk Scientific, Inc., Orem, UT,
USA) was used to semiquantitate the fragmented DNA.
The densitometry of the DNA fragments that appeared
below 2070 bp was recorded. This measurement was nor-
malized against the density of the total genomic DNA of
the sample to correct for DNA loading. The density of the
total genomic DNA of each sample was calculated as the
sum of the density of the DNA fragments below 2070 bp
plus the density of the large DNA band found above the
2070 bp marker. In addition, to allow comparisons
between different gels, the normalized densitometric val-
ues for each of the incubation times were divided by the
normalized densitometric values at time zero of incuba-
tion. The samples of DNA used for time zero of incuba-
tion were obtained from CL that were isolated for ex vivo
incubation but were frozen without being incubated.
Hormone assays
Estradiol concentrations were measured by radioimmu-
noassay (RIA) using a commercially obtained kit (Diag-
nostics Systems Laboratories, Webster, TX, USA). The
sensitivity was 2.2 pg/ml, and the inter- and intra-assay
coefficients of variation were 7.5% and 9.3% respectively.
Androstenedione was assayed using a RIA previously
described [9]. The sensitivity of the assay was 6 pg/tube
and the intra- and inter-assay coefficients of variation
were 4.4% and 16.7% respectively. Progesterone was
assayed by enzyme immunoassay (EIA) using a commer-
cially obtained kit (Cayman Chemical, Ann Arbor, MI,
USA). The sensitivity of the assay was 10 pg/ml, and the
inter- and intra-assay coefficients of variation were 5%
and 6% respectively. Rat prolactin was assayed by EIA
using a commercial kit (SPIbio, Massy Cedex, France). The
sensitivity of the assay was 0.5 ng/ml and the intra- and
inter-assay coefficients of variation were 8.1% and 14%
respectively.
RNA isolation and reverse transcription polymerase chain 
reaction
The CL from rats on day 15 of pregnancy or on day 4 post-
partum were obtained and total RNA was extracted using
TRIzol (Invitrogen, Carlsbad, CA, USA) per manufac-
turer's instructions. Reverse transcription (RT) reaction
and polymerase chain reaction (PCR) were done using a
SuperScript One-Step RT-PCR system with Platinum Taq
(Invitrogen). PCR was carried out in a GeneAmp PCRReproductive Biology and Endocrinology 2005, 3:40 http://www.rbej.com/content/3/1/40
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2700 thermal cycler (Applied Biosystems, Foster City, CA,
USA) for 25 cycles using 61°C as the annealing tempera-
ture. The conditions were such that the amplification of
the products was in the exponential phase, and the assay
was linear with respect to the amount of input RNA. Oli-
gonucleotide primer pairs were based on the sequence of
the rat ERalpha gene (5'-AATTCTGACAATCGACGCCAG-
3') and (5'-GTGCTTCAACATTCTCCCTCCTC-3'), the rat
ERbeta gene (5'-AAAGCCAAGAGAAACGGTGGGCAT-3')
and (5'-GCCAATCATGTGCACCAGTTCCTT-3'), and the
rat ribosomal protein L19 (used as a housekeeping gene)
(5'-CTGAAGGTCAAAGGGAATGTG-3') and (5'-GGACA-
GAGTCTTGATATCTC-3'), as previously described
[15,20]. The predicted sizes of the PCR-amplified prod-
ucts were 344 (ERalpha), 204 (ERbeta) and 194 (L19).
The PCR products were run on a 2.5% agarose gel, stained
with SYBR Gold nucleic acid gel stain (Molecular Probes),
and photographed with the Amersham Typhoon imaging
system (Amersham). A 100 bp DNA ladder (Promega)
was used for determining the size of the PCR products.
Statistics
Comparisons between means of two groups were carried
out using Student t-tests. For multiple comparisons, one-
way analysis of variance followed by Tukey's or Dunnet's
multiple comparison test was used. A difference was con-
sidered to be statistically significant at P < 0.05.
Results
Potentiation of apoptosis by estradiol benzoate in the 
post-partum CL
To study the effect of estradiol on apoptosis during luteal
regression, we used rats whose pups were removed imme-
diately after delivery to prevent the initiation of lactation.
Under these conditions, the animals undergo extensive
luteal regression in both generations of CL (i.e., old CL of
previous pregnancy and newly formed CL after post-par-
tum ovulation) by day 3–4 post-partum [10,21]. Figure 1
shows representative images of H&E stained sections from
CL of non-lactating animals treated with vehicle or estra-
diol benzoate and sacrificed on day 4 after parturition.
The CL of vehicle-treated controls displayed few apoptotic
nuclei per microscope field (Figure 1A), whereas treat-
ment with estradiol benzoate markedly enhanced the
number of apoptotic figures (Figure 1B). The images
depicted in this figure correspond to an old CL of preg-
nancy, but similar images were observed in newly formed
CL after post-partum ovulation (data not shown). Figures
2A and 2B show the quantification of apoptotic nuclei
found within both generations of CL in vehicle-treated
rats and in rats receiving estradiol benzoate. The average
weight of the CL seen in control animals on day 4 post-
partum was not affected by treatment with the estrogen
(Figures 2C and 2D).
Circulating concentrations of 17beta-estradiol, 
androstenedione, progesterone and prolactin in animals 
treated with estradiol benzoate after parturition
Animals that were treated with estradiol benzoate, as
expected, displayed elevated circulating levels of 17beta-
estradiol (Figure 3A). Androstenedione, shown to be
capable of interfering with luteal regression in post-par-
tum rat CL [9], did not change with estrogen treatment
(Figure 3B). Prolactin, one of the main hormones
involved in CL function in rats, had a significant increase
in its circulating concentration after treatment with
estradiol benzoate (Figure 3C), in parallel with a
Micrographs of CL obtained from rats killed on day 4 post- partum and stained with H&E Figure 1
Micrographs of CL obtained from rats killed on day 4 
post-partum and stained with H&E. Panel (A) shows the 
structure of a an old CL of pregnancy obtained from an ani-
mal treated with vehicle, whereas panel (B) displays the 
structure of an old CL of pregnancy obtained from a rat 
treated with estradiol benzoate. Similar results were 
observed in newly formed CL after post-partum ovulation 
obtained from animals receiving vehicle or estradiol ben-
zoate. The arrows indicate nuclei undergoing apoptosis dis-
playing different features of chromatin condensation. 
Magnification × 400.
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significant increase in circulating levels of progesterone
(Figure 3D).
Bromoergocryptine abrogates estradiol benzoate-induced 
increase in serum prolactin and progesterone 
concentrations in post-partum rats
Because it is known that in pregnant rats prolactin stimu-
lates the production of progesterone by the CL [22], we
evaluated whether the enhanced circulating levels of pro-
gesterone in response to treatment with estradiol ben-
zoate were the consequence of a direct effect of the
estrogen on the ovary, or instead, an indirect effect medi-
ated by prolactin secreted in response to estradiol. To
answer this question, we injected post-partum animals
with estradiol benzoate plus bromoergocryptine in order
to block the production of pituitary prolactin induced by
the estrogen. The serum concentrations of prolactin and
progesterone, which were increased by administration of
estradiol benzoate, were abrogated by bromoergrocryp-
tine, reaching control levels (Table 1). These results sug-
gest that the increase in the production of progesterone in
estrogen-treated animals is most likely a consequence of
an effect of prolactin rather than a direct effect of estradiol
on the ovary.
Bromoergocryptine abrogates estradiol benzoate 
enhancement of ex vivo-induced luteal DNA 
fragmentation
To further study the effect of estradiol on apoptotic cell
death in the rat CL, we used a previously defined ex vivo
approach in which CL incubated in serum-free conditions
Effect of treatment with estradiol benzoate on CL apoptosis  and weight in the rat ovary after parturition Figure 2
Effect of treatment with estradiol benzoate on CL 
apoptosis and weight in the rat ovary after parturi-
tion. Ovaries were obtained at 13:00 hon day 4 post-partum 
from animals that had received vehicle (V) [non-lactating ani-
mals treated daily with sunflower seed oil at 10:00 h (n = 6–
8)], or estradiol benzoate (EB) [non-lactating animals treated 
daily with estradiol benzoate (5 µg/rat s.c.) at 1000 h (n = 6–
8)]. The ovaries were processed for routine H&E staining, 
and the number of apoptotic figures was counted under a 
light microscope (A and B). The average weight of the CL 
was recorded in two other groups of 6 to 8 animals (C and 
D). Filled bars represent old CL of gestation, whereas open 
bars represent newly formed CL after ovulation post-par-
tum. *** p < 0.001 compared with vehicle (Student t-test).
(
n
u
m
b
e
r
p
e
r
h
i
g
h
p
o
w
e
r
f
i
e
l
d
x
1
0
)
A
p
o
p
t
o
t
i
c
N
u
c
l
e
i
V
V
m
g
/
C
L
/
r
a
t
V
m
g
/
C
L
/
r
a
t
A
p
o
p
t
o
t
i
c
N
u
c
l
e
i
EB
EB EB
0
10
20
30
40
50
60
0
10
20
30
40
50
60
∗∗∗
∗
∗
∗
0
1
2
3
0.0
0.5
1.0
1.5
EB V
A
B
C
D
Apoptosis Weight
(
n
u
m
b
e
r
p
e
r
h
i
g
h
p
o
w
e
r
f
i
e
l
d
x
1
0
)
Serum hormone concentrations in post-partum non-lactating  animals treated with vehicle or estradiol benzoate Figure 3
Serum hormone concentrations in post-partum non-
lactating animals treated with vehicle or estradiol 
benzoate. 17beta-estradiol (A), androstenedione (B), prol-
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non-lactating animals treated daily at 10:00 h with either 
vehicle (V) or estradiol benzoate (EB; 5 µg/rat s.c.), and killed 
at 13:00 h on day 4 post-partum. *** p < 0.001 compared 
with vehicle-treated animals (Student t-test).
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accumulate large number of cells in different stages of
apoptosis. This approach is sensitive to study hormonal
regulation of apoptosis in the CL [8-10,23]. It takes 2 to 4
h of organ culture to observe DNA fragmentation [8],
whereas the length of this period depends upon the hor-
monal environment to which the gland had been exposed
in vivo. In the current work, old CL obtained from non-
lactating rats on day 4 post-partum and incubated in
serum-free conditions displayed DNA fragmentation in a
time-dependent manner (Figure 4A, left panel, and 4B).
However, in non-lactating rats that had received a daily
injection of estradiol benzoate from days 1 to 4 post-par-
tum, the ex vivo-induced luteal DNA fragmentation was
markedly accelerated and more abundant (Figure 4A,
middle panel, and 4B). When the animals were treated
with estradiol benzoate in conjunction with bromoergoc-
ryptine, the temporal pattern of DNA fragmentation ex
vivo, as well as the abundance of fragmented DNA, was
comparable to that of vehicle-treated animals (Figure 4A,
right panel, and 4B). These data indicate that the blockage
of estradiol-induced prolactin secretion prevents fragmen-
tation of DNA induced by the estrogen, and suggest that
the pro-apoptotic signal triggered by estrogen on the post-
partum CL is most likely the consequence of the action of
prolactin.
Expression of ER in the post-partum rat CL
To determine whether ERalpha and ERbeta genes are
expressed in the rat CL post-partum, we performed semi-
quantitative RT-PCR to specifically detect the ERalpha and
ERbeta mRNA transcripts. As a positive control for ER
mRNA expression we used CL obtained from day 15 preg-
nant rats, which were previously described as expressing
both ER mRNA transcripts [15]. Figure 5A shows that
ERalpha and ERbeta mRNA transcripts are highly
expressed 4 days after parturition in both types of CL
found within the ovaries. Semiquantitative analysis
(Figure 5B) shows no difference between the abundance
of each ER transcript on the different days analyzed as well
as when comparing new and old types of CL on day 4
post-partum. These data also indicate that the post-par-
tum CL can be direct targets of estrogen action.
Discussion
The pro- or anti-apoptotic effects of estrogens are contro-
versial. For example, estradiol enhances neuronal survival
[24,25], but sensitizes anterior pituitary gland to
Table 1: Effect of bromoergrocryptine (BEC) on serum concentrations of progesterone and prolactin in post-partum non-lactating 
rats treated with estradiol benzoate (EB).
Vehicle EB EB + BEC
Progesterone (ng/ml) 45.9 ± 7.2 (10) 154 ± 13.3 (10) *** 44.6 ± 6.7 (9)
Prolactin (ng/ml) 30.2 ± 4.2 (10) 166 ± 19.2 (10) *** 25.5 ± 6.5 (9)
Values are mean ± SEM for the number of animals in parentheses. *** p < 0.001 compared with groups receiving vehicle or EB + BEC (one-way 
analysis of variance followed by the Tukey multiple comparison test).
Effect of estradiol benzoate or estradiol benzoate plus bro- moergocryptine on DNA fragmentation in CL incubated in  serum-free conditions Figure 4
Effect of estradiol benzoate or estradiol benzoate 
plus bromoergocryptine on DNA fragmentation in 
CL incubated in serum-free conditions. At the end of 
the incubation, genomic DNA was extracted from vehicle-
treated, estradiol benzoate (EB)-treated or EB plus bromoer-
grocriptine (BEC)-treated animals and run on a gel (Panel A). 
Densitometry of the DNA fragments studied from three dif-
ferent experiments with similar outcome is also shown (Panel 
B). * p < 0.05, ** p < 0.01 and *** p < 0.001 compared with 
values at time zero (one way analysis of variance followed by 
the Dunnett multiple-comparison test). † P < 0.05 and †† P < 
0.01 compared with the corresponding time across treat-
ments (one way analysis of variance followed by the Tukey 
multiple comparison test). bp, Base pairs. Only CL of previ-
ous pregnancy were evaluated.
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apoptosis [26]. We have shown that estradiol enhances
apoptosis in regressing CL of rats. In rabbits, however,
estradiol protects the CL from apoptosis [27]. Thus, the
effect of estradiol on apoptosis appears to be cell and spe-
cies dependent.
A role for estradiol in the induction of apoptosis has been
suggested for the CL of primates. Prior to the induction of
apoptosis the human CL express high levels of 17beta-
hydroxysteroid dehydrogenase type I, the enzyme that
converts estrone to estradiol [28], suggesting a role for
locally produced estradiol in triggering luteal regression.
An increase in the sensitivity to estradiol has also been
proposed in the CL of monkeys coincident with luteal
regression [29]. Further, in a recent review on apoptosis in
the human ovary, a role for estradiol has been suggested
in triggering luteal regression [30]. Our results in regress-
ing rat CL support a similar effect of estradiol to that
shown in humans, stimulating luteal regression through
the promotion of luteal apoptosis, and suggest that the
elevated estrogenic environment to which the CL of rats
are exposed at the time of parturition [13,14] may play a
role in the post-partum facet of luteal regression.
In our studies, the pro-apoptotic effect of estradiol
appears to rely on the presence of pituitary prolactin. The
stimulation of prolactin secretion by estradiol in rats has
been demonstrated in several in vivo settings. For exam-
ple, estradiol implants made in the arquate nucleus pro-
voke a sustained release of prolactin [31], whereas
systemic administration of estradiol benzoate in
ovariectomized rats stimulates prolactin secretion by a
mechanism that involves the opioid system [32]. Further-
more, estradiol can also stimulate prolactin synthesis and
release by directly targeting the lactotrophes [33].
One interesting finding in our study is that exogenous
estradiol increased apoptosis in the CL while at the same
time increased serum progesterone levels. An interaction
between estrogen, progesterone and prolactin has been
shown during the regression of the CL of the rat estrous
cycle [34]. These authors demonstrated that antiestrogens
decrease the detrimental effect of prolactin on the CL,
whereas progesterone favors the action of prolactin, sug-
gesting that an estrogenic and progestational hormonal
environment favors apoptosis induced by prolactin. Our
results are in keeping with this because the increased
apoptosis induced by estradiol in the post-partum rat CL
also occurred in the presence of elevated concentrations of
progesterone and prolactin.
The effect of estrogen on progesterone production in rats
varies with the experimental approach. For example, in
hypophysectomized and hysterectomized rats estradiol
stimulates the production of progesterone [35]. In con-
trast, in pseudopregnant rats, treatment with estradiol
benzoate decreases plasma levels of progesterone [36],
and, in pregnant rats, estradiol given from days 7 to 14 of
pregnancy reduces the levels of circulating progesterone
measured on day 15 of pregnancy [37]. In our study using
intact rats after parturition estrogen treatment increased
progesterone production and such effect seems mediated
by pituitary prolactin because it could be abrogated by
bromoergocryptine.
Prolactin has different effects on the CL depending on the
prevailing steroid concentrations. For example during
Expression of ERalpha and ERbeta mRNA in the two popula- tions of CL found in the post-partum ovaries Figure 5
Expression of ERalpha and ERbeta mRNA in the two 
populations of CL found in the post-partum ovaries. 
Old indicates CL from previous pregnancy. New indicates 
newly formed CL after post-partum ovulation. Total RNA 
was isolated from old or new CL on day 4 post-partum, and 
from CL obtained from animals on day 15 of pregnancy, and 
was analyzed by RT-PCR. In panel (A) a representative gel is 
shown. Results were quantified by densitometry and cor-
rected using L19. Normalized mRNA levels are graphically 
represented in panel (B) as the mean ± SEM (n = 3).
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lactation, prolactin prevents apoptosis in the CL [8,12].
This effect of prolactin occurs in the presence of high cir-
culating levels of progesterone [8], at least until day 9 of
lactation [12]. In this physiological situation, estradiol
levels are low and beginning to increase towards the 8th to
10th day of lactation [38]. Conversely, our studies in non-
lactating post-partum rats receiving estradiol suggest that
prolactin stimulates rather than prevents luteal apoptosis,
and that this effect takes place in the presence of high pro-
gesterone. Together these studies suggest that prolactin
may stimulate progesterone production, but at the same
time may either trigger or prevent luteal apoptosis
depending upon the estrogenic background. Whereas a
high estrogenic background may favor a pro-apoptotic
action of prolactin (e.g. as in the cyclic rat CL), a low estro-
genic background may favor an anti-apoptotic effect of
the hormone (e.g. as in the CL of lactation). Further stud-
ies need to be done to prove or disprove this hypothesis,
but answering this question may resolve the unclear issue
that prolactin appears to have a dual effect in the rat CL,
being both a survival factor [8,20,22,39] and a pro-apop-
totic factor [3,40-46]. It is feasible that opposite actions of
prolactin in the CL, driven by the estrogenic environment,
are mediated through different signal transduction path-
ways activated by the lactogenic hormone upon binding
to its luteal receptor subtypes [20,47], or by differential
activation and turnover of transcription factors [48].
A direct effect of prolactin on the regressing CL after par-
turition is supported by the presence of receptors for pro-
lactin in both old CL of pregnancy and newly formed CL
after ovulation post-partum [8]. Whereas the expression
of prolactin receptors in estrogen-treated animals was not
measured in the present study, we can anticipate their
presence. This is because prolactin has been shown to up-
regulate its own receptors in the CL [20]; thus, it is
unlikely that in an environment high in prolactin as
observed in estrogen-treated rats, those receptors would
have been reduced.
In the present study, we have shown that the ER genes are
expressed in post-partum CL making them potential
direct targets for the action of estradiol. As we only studied
the expression of the ER mRNAs, we cannot conclusively
indicate that the ER proteins follow similar expression
pattern. Yet, most probably the latter assumption is true
because a correlation was shown between expression of
ER message and protein in the pregnant rat CL [15]. The
rat CL express ERalpha and ERbeta mRNAs and ER immu-
noreactive proteins along pregnancy, with a decline in
expression occurring at parturition [15]. Because the post-
partum CL express ER transcripts at levels similar to the
levels measured at mid-pregnancy, it can be suggested that
the down-regulation of ER expression in the rat CL is lim-
ited to parturition.
Previously, we demonstrated that the main circulating
androgen in female rats, androstenedione, protects the
post-partum CL from undergoing apoptosis [9]. In the
present report we show that estradiol enhances apoptosis
in the same CL types. Taken together, the results of these
two studies suggest that androgens and estrogens oppose
each other's action on luteal apoptosis. This opposite
effect of androgens and estrogens also occurs in granulosa
cells, with however, a different pattern. Rat granulosa cells
maintained in culture respond to testosterone with an
increase in apoptosis, and to estradiol with a decrease in
apoptosis [49]. Whereas an increase in the androgen to
estrogen ratio in the follicular fluid favors apoptosis of
granulosa cells and overall follicular atresia [50,51], a sim-
ilar change in ratio within the CL may protect the gland
from regression.
Conclusion
We have shown that estradiol increases apoptosis in the
rat CL during post-partum luteal regression and presented
evidence suggesting that pituitary prolactin is the
mediator of such effect. We also demonstrated the expres-
sion of ERalpha and ERbeta mRNA transcripts in the two
populations of CL found in this species after parturition
(i.e. the newly formed CL after post-partum ovulation and
the old CL of pregnancy). Moreover, the data suggest that
the estrogenic environment might be a key factor driving
a detrimental effect of prolactin in the post-partum CL.
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